Upstate Active Clinical Trials
Study Title:
AALL1631 - International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbonesWhat is the purpose of the study? (in Layman's terms, please describe the study)
trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbonesUpstate Institutional Review Board (IRB) Number:
1111949Study/Protocol ID:
AALL1631Study Phase:
IIIPatient Age Group:
ChildrenPrincipal Investigator:
Melanie A ComitoWho is eligible?
≥ 1 year (365 days) and ≤ 21 years at ALL diagnosisWhat is involved if I participate?
- How long is the study?
until accrual is met - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
lab draws, lumbar punctures, bone marrow biopsy/aspirate
Where will the study take place?
SUNY Upstate Medical UniversityOther Information:
N/AWho can I contact for more information?
Name: Karen B Bilynsky
Phone: 315-464-7601
Email: [email protected]